Annual balance sheet for IN8bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 37 | 18.2 | 21.3 | 11.1 | 27.1 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 39 | 22.2 | 24.6 | 12.6 | 27.9 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2.83 | 10.3 | 8.57 | 7.83 | 4.04 |
| Other Long Term Assets | |||||
| Total Assets | 42.2 | 33 | 33.7 | 20.9 | 32.3 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Current Liabilities | 2.26 | 5.82 | 5.39 | 3.08 | 3.16 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 4.04 | 10.3 | 8.77 | 6.47 | 4.72 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 38.2 | 22.7 | 24.9 | 14.5 | 27.6 |
| Total Liabilities & Shareholders' Equity | 42.2 | 33 | 33.7 | 20.9 | 32.3 |
| Total Common Shares Outstanding |